Medicare Enrolled

Dr. Daniel Parnassa, MD

Cardiovascular Disease · Sebring, FL
Practice pattern: Electrophysiology & Remote— Practice combining electrophysiology and remote services
Low-engagement
2227 US HIGHWAY 27 S UNIT 101, Sebring, FL 33870
8633854300
In practice since 2005 (20 years)
NPI: 1528049483 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Parnassa from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Parnassa? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Parnassa

Dr. Daniel Parnassa is a cardiovascular disease in Sebring, FL, with 20 years in practice. Based on federal Medicare data, Dr. Parnassa performed 8,767 Medicare services across 5,462 unique beneficiaries.

Between the years covered by Open Payments, Dr. Parnassa received a total of $13,976 from 35 pharmaceutical and/or device companies across 582 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Parnassa is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 9% volume in FL$ $13,976 industry payments

Medicare Practice Summary

Medicare Utilization ↗
8,767
Medicare services
Top 9% in FL for cardiovascular disease
5,462
Unique beneficiaries
$53
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~438 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)2,235$91$192
Electrocardiogram (EKG), 12-lead1,988$10$25
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec498$26$75
Evaluation of cardiac rhythm monitor system, remote up to 30 days478$19$28
Echocardiogram, transthoracic470$143$284
Ultrasound of both sides of head and neck blood flow343$139$275
Remote pacemaker/defibrillator monitoring, 90 days336$16$29
Remote pacemaker monitoring, 90 days282$21$34
New patient office visit (45-59 min)277$122$360
Office visit, established patient (20-29 min)207$65$136
Initial hospital admission, moderate complexity200$98$162
Evaluation of single, dual, multiple lead or leadless pacemaker system189$14$49
Anticoagulant management of patient taking warfarin179$9$28
Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent164$7$25
Programming of dual lead pacemaker system154$25$77
Heart rhythm review and interpretation of continous external ekg over 8-15 days126$20$68
Prothrombin time test (blood clotting)77$4$11
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional74$8$38
Injection, perflutren lipid microspheres, per ml64$36$182
Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days57$26$68
Programming of cardiac rhythm monitor system50$19$63
Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and45$40$63
Evaluation of single, dual, or multiple lead implantable defibrillator system40$25$84
Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a39$30$47
Evaluation of cardiac rhythm monitor system38$12$47
Injection of drug or substance into vein34$28$56
Programming of multiple lead implantable defibrillator system31$44$118
Programming of multiple lead pacemaker system24$27$89
Programming of dual lead implantable defibrillator system21$36$108
Ultrasound of leg arteries or artery grafts17$128$182
Ultrasound study of arm or leg veins with compression and maneuvers17$88$182
Ultrasound of heart, follow-up13$69$123
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
20.2% high complexity
5.6% medium
74.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$13,976
Total received (2018-2024)
Avg $1,997/year across 7 years
Top 18% in FL for cardiovascular disease
35
Companies
582
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,519 (96.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$457 (3.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,466
2023
$2,195
2022
$2,297
2021
$1,547
2020
$1,495
2019
$1,896
2018
$3,080

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$2,362
Janssen Pharmaceuticals, Inc
$1,342
Amgen Inc.
$1,166
AstraZeneca Pharmaceuticals LP
$801
Abbott Laboratories
$771
E.R. Squibb & Sons, L.L.C.
$680
Alnylam Pharmaceuticals Inc.
$645
Novartis Pharmaceuticals Corporation
$600
SANOFI-AVENTIS U.S. LLC
$567
Merck Sharp & Dohme LLC
$544
Boehringer Ingelheim Pharmaceuticals, Inc.
$520
Astellas Pharma US Inc
$438
PFIZER INC.
$350
Amarin Pharma Inc.
$330
BIOTRONIK INC.
$311
Philips Electronics North America Corporation
$289
Esperion Therapeutics, Inc.
$289
Regeneron Healthcare Solutions, Inc.
$235
Actelion Pharmaceuticals US, Inc.
$183
CVRx, Inc.
$178
Merck Sharp & Dohme Corporation
$177
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$177
Philips North America LLC
$176
Braemar Manufacturing, LLC
$154
Bayer HealthCare Pharmaceuticals Inc.
$145
GENZYME CORPORATION
$125
Bayer Healthcare Pharmaceuticals Inc.
$107
Lilly USA, LLC
$93
Novo Nordisk Inc
$78
BOSTON SCIENTIFIC CORPORATION
$33
Medtronic Vascular, Inc.
$32
Kestra Medical Technology Services, Inc.
$29
Inspire Medical Systems, Inc.
$23
Ethicon US, LLC
$12
Coala Life Inc
$12
Top 3 companies account for 34.8% of total payments
Associated products mentioned in payments ›
(5044) MCOT · (5050) Ext Holter · (5050) Extended Holter · (7999) SRC Undivided · (9278) Bridge · (CK7) Extended Holter · AMVIA EDGE · AMVUTTRA · AVEIR · Acticor · Acticor 7 VR-T DX · Asahi Fielder coronary guide wire · Assure WCD · Assurity Pacemaker · BRILINTA · BYDUREON · Barostim Neo System · BioMonitor · CAMZYOS · Cardiac Monitoring Suite · ClosureFast · Coala Heart Monitor · Confirm Rx · Corlanor · ELIQUIS · ENTRESTO · Edora · FARXIGA · General - Therapies · INSPIRE · INVOKANA · JARDIANCE · Kerendia · LEQVIO · LEXISCAN · LINX Reflux Management System · LOKELMA · LUX-Dx Insertable Cardiac Monitor · Lexiscan · LifeVest · MERLIN@HOME · MITRACLIP · MULTAQ · Mitra Clip system · MitraClip System · NEXLETOL · NEXLIZET · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Pacemakers · RESONATE EL ICD VR · Repatha · Reveal LINQ · Rivacor · Rivacor 7 DR-T · STIOLTO RESPIMAT · Solia · VERQUVO · VYNDAMAX · VYNDAQEL · Vascepa · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · Xultophy 100/3.6
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $159 per 100 Medicare services performed
Looking for a cardiovascular disease in Sebring?
Compare cardiovascular diseases in the Sebring area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
10
Per 100K population
9.6
County median income
$55,581
Nearest hospital
HCA FLORIDA HIGHLANDS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Parnassa is a electrophysiology & remote specialist, with above-average Medicare volume (top 9% in FL), and high industry engagement (low-engagement, top 18%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Parnassa experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Parnassa performed 2,235 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Parnassa receive payments from pharmaceutical companies?
Yes. Dr. Parnassa received a total of $13,976 from 35 companies across 582 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Parnassa's costs compare to other cardiovascular diseases in Sebring?
Dr. Parnassa's average Medicare payment per service is $53. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Parnassa) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →